• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.在线工具预测的变异性:基于互联网的黑色素瘤预测器的演示。
Ann Surg Oncol. 2018 Aug;25(8):2172-2177. doi: 10.1245/s10434-018-6370-4. Epub 2018 Feb 22.
2
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.发展和外部验证两种列线图,以预测成人肢体局限性软组织肉瘤手术后的总生存和远处转移发生:回顾性分析。
Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.
3
A web-based tool for the assessment of discrimination and calibration properties of prognostic models.一种用于评估预后模型的区分度和校准度属性的基于网络的工具。
Comput Biol Med. 2008 Jul;38(7):785-91. doi: 10.1016/j.compbiomed.2008.04.005. Epub 2008 Jun 9.
4
The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort.纪念斯隆凯特琳癌症中心列线图比 2009 年 FIGO 分期系统在预测德国子宫内膜癌患者队列的总生存期中更准确。
Ann Surg Oncol. 2018 Dec;25(13):3966-3973. doi: 10.1245/s10434-018-6756-3. Epub 2018 Sep 20.
5
ASO Author Reflections: Careful Development and Thoughtful Interpretation are Needed when Developing Online Prognostic Tools.ASO作者反思:开发在线预后工具时需要谨慎开发和深思熟虑的解读。
Ann Surg Oncol. 2018 Dec;25(Suppl 3):916-917. doi: 10.1245/s10434-018-6987-3. Epub 2018 Nov 1.
6
Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population.纪念斯隆凯特琳癌症中心列线图在中国结肠癌患者群体中预测根治性结肠切除术后总生存期的验证
Ann Surg Oncol. 2015 Nov;22(12):3881-7. doi: 10.1245/s10434-015-4495-2. Epub 2015 May 12.
7
Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands.涎腺主要癌症总生存、癌症特异性生存及复发列线图的验证
Head Neck. 2018 May;40(5):1008-1015. doi: 10.1002/hed.25079. Epub 2018 Feb 1.
8
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.澳大利亚前列腺癌患者三种风险评估工具的比较分析。
BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.
9
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.个性化医疗:接受伊匹木单抗治疗的转移性黑色素瘤患者预后模型的开发与外部验证
Eur J Cancer. 2015 Sep;51(14):2086-94. doi: 10.1016/j.ejca.2015.06.130. Epub 2015 Jul 27.
10
Action profiles of predictors of death and survival time in stage I malignant melanoma.I期恶性黑色素瘤死亡和生存时间预测因素的作用模式
Dermatology. 1996;192(1):1-7. doi: 10.1159/000246303.

引用本文的文献

1
Combining Missing Data Imputation and Internal Validation in Clinical Risk Prediction Models.临床风险预测模型中的缺失数据插补与内部验证相结合
Stat Med. 2025 Aug;44(18-19):e70203. doi: 10.1002/sim.70203.
2
Primary Cutaneous Melanoma-Management in 2024.原发性皮肤黑色素瘤——2024年的管理
J Clin Med. 2024 Mar 11;13(6):1607. doi: 10.3390/jcm13061607.
3
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.利用临床病理和基因表达模型识别 I/IIA 期黑色素瘤患者中疾病复发的高危人群。
Eur J Cancer. 2020 Nov;140:11-18. doi: 10.1016/j.ejca.2020.08.029. Epub 2020 Oct 5.
4
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.澳大利亚黑色素瘤研究所列线图:改良的黑色素瘤患者前哨淋巴结阳性风险预测计算器。
J Clin Oncol. 2020 Aug 20;38(24):2719-2727. doi: 10.1200/JCO.19.02362. Epub 2020 Jun 12.
5
ASO Author Reflections: Careful Development and Thoughtful Interpretation are Needed when Developing Online Prognostic Tools.ASO作者反思:开发在线预后工具时需要谨慎开发和深思熟虑的解读。
Ann Surg Oncol. 2018 Dec;25(Suppl 3):916-917. doi: 10.1245/s10434-018-6987-3. Epub 2018 Nov 1.
6
Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.建立并验证一种列线图模型,以预测前哨淋巴结阴性黑色素瘤患者的复发和黑色素瘤特异性死亡率。
Br J Surg. 2019 Feb;106(3):217-225. doi: 10.1002/bjs.10995. Epub 2018 Oct 11.

本文引用的文献

1
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature.临床预测模型的判别与校准:医学文献的使用者指南。
JAMA. 2017 Oct 10;318(14):1377-1384. doi: 10.1001/jama.2017.12126.
2
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.纳武利尤单抗辅助治疗与伊匹单抗用于切除的 III 期或 IV 期黑色素瘤。
N Engl J Med. 2017 Nov 9;377(19):1824-1835. doi: 10.1056/NEJMoa1709030. Epub 2017 Sep 10.
3
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.辅助达拉非尼联合曲美替尼治疗 BRAF 突变型 III 期黑色素瘤。
N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10.
4
Critical Assessment of Clinical Prognostic Tools in Melanoma.黑色素瘤临床预后工具的批判性评估
Ann Surg Oncol. 2016 Sep;23(9):2753-61. doi: 10.1245/s10434-016-5212-5. Epub 2016 Apr 6.
5
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.美国癌症联合委员会关于在精准医学实践中纳入个性化预后风险模型的纳入标准。
CA Cancer J Clin. 2016 Sep;66(5):370-4. doi: 10.3322/caac.21339. Epub 2016 Jan 19.
6
Predicting cancer prognosis using interactive online tools: a systematic review and implications for cancer care providers.使用交互式在线工具预测癌症预后:系统评价及对癌症护理提供者的影响。
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1645-56. doi: 10.1158/1055-9965.EPI-13-0513. Epub 2013 Aug 16.
7
A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.一种新的、准确的黑色素瘤预后计算机模型,用于接受前哨淋巴结活检分期的患者:与美国癌症联合委员会模型的比较。
J Am Coll Surg. 2012 Apr;214(4):608-17; discussion 617-9. doi: 10.1016/j.jamcollsurg.2011.12.027. Epub 2012 Feb 17.
8
Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.预测局限性黑色素瘤的生存结局:基于 AJCC 黑色素瘤数据库的电子预测工具。
Ann Surg Oncol. 2010 Aug;17(8):2006-14. doi: 10.1245/s10434-010-1050-z. Epub 2010 Apr 9.
9
Final version of 2009 AJCC melanoma staging and classification.2009 年 AJCC 黑色素瘤分期与分类的最终版。
J Clin Oncol. 2009 Dec 20;27(36):6199-206. doi: 10.1200/JCO.2009.23.4799. Epub 2009 Nov 16.
10
How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.原发部位及淋巴结处的癌症如何导致癌症死亡风险。
Cancer. 2009 Nov 1;115(21):5095-107. doi: 10.1002/cncr.24592.

在线工具预测的变异性:基于互联网的黑色素瘤预测器的演示。

Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2018 Aug;25(8):2172-2177. doi: 10.1245/s10434-018-6370-4. Epub 2018 Feb 22.

DOI:10.1245/s10434-018-6370-4
PMID:29470818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6219459/
Abstract

BACKGROUND

Prognostic models are increasingly being made available online, where they can be publicly accessed by both patients and clinicians. These online tools are an important resource for patients to better understand their prognosis and for clinicians to make informed decisions about treatment and follow-up. The goal of this analysis was to highlight the possible variability in multiple online prognostic tools in a single disease.

METHODS

To demonstrate the variability in survival predictions across online prognostic tools, we applied a single validation dataset to three online melanoma prognostic tools. Data on melanoma patients treated at Memorial Sloan Kettering Cancer Center between 2000 and 2014 were retrospectively collected. Calibration was assessed using calibration plots and discrimination was assessed using the C-index.

RESULTS

In this demonstration project, we found important differences across the three models that led to variability in individual patients' predicted survival across the tools, especially in the lower range of predictions. In a validation test using a single-institution data set, calibration and discrimination varied across the three models.

CONCLUSIONS

This study underscores the potential variability both within and across online tools, and highlights the importance of using methodological rigor when developing a prognostic model that will be made publicly available online. The results also reinforce that careful development and thoughtful interpretation, including understanding a given tool's limitations, are required in order for online prognostic tools that provide survival predictions to be a useful resource for both patients and clinicians.

摘要

背景

预后模型越来越多地在网上提供,患者和临床医生都可以公开访问这些在线工具。这些在线工具是患者更好地了解自身预后的重要资源,也是临床医生在治疗和随访方面做出明智决策的重要资源。本分析的目的是强调单一疾病中多个在线预后工具之间可能存在的差异。

方法

为了展示在线预后工具中生存预测的可变性,我们将一个验证数据集应用于三个在线黑色素瘤预后工具。回顾性收集了 2000 年至 2014 年在纪念斯隆凯特琳癌症中心治疗的黑色素瘤患者的数据。使用校准图评估校准,使用 C 指数评估区分度。

结果

在这个演示项目中,我们发现三个模型之间存在重要差异,导致工具之间个别患者的预测生存存在差异,尤其是在预测范围较低的情况下。在使用单机构数据集的验证测试中,三个模型的校准和区分度存在差异。

结论

这项研究强调了在线工具内部和跨工具之间的潜在可变性,并强调了在开发将在线公开提供的预后模型时采用严格方法的重要性。研究结果还强调,为了使提供生存预测的在线预后工具成为患者和临床医生的有用资源,需要仔细开发和深思熟虑的解释,包括了解给定工具的局限性。